Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rare metabolic diseases].

U Wendel1, P Burgard

  • 1Klinik für Allgemeine Pädiatrie, Heinrich-Heine Universität Düsseldorf, BRD. wendelu@uni-duesseldorf.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Metabolic Phenotype in Phenylketonuria: Evaluation of the Blaskovics Protein Loading Test at 5 Years of Age.

JIMD reports·2015
Same author

Human branched-chain L-amino acid aminotransferase: Activity and subcellular localization in cultured skin fibroblasts.

Amino acids·2013
Same author

Structural white matter changes in adolescents and young adults with maple syrup urine disease.

Journal of inherited metabolic disease·2013
Same author

Compartmental approach for evaluation of plasma kinetics and (13)co(2)-exhalation after oral loading with L-[1-(13)c]leucine.

Isotopes in environmental and health studies·2011
Same author

Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test.

Journal of inherited metabolic disease·2009
Same author

Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control.

Journal of inherited metabolic disease·2009
Same journal

[The progress of participation research. A sociological analysis of its institutionalization].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Rare metabolic diseases require specialized care centers for comprehensive treatment and continuous improvement. Networking these centers is crucial for effective clinical research and better patient outcomes.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Context:

  • Rare metabolic diseases are chronic, progressive, and often life-threatening conditions.
  • These diseases necessitate high diagnostic and therapeutic standards, demanding significant effort from healthcare professionals and patients.
  • Societal and health system challenges include providing comprehensive services and evidence-based, cost-effective treatments.

Purpose:

  • To outline the essential components of managing rare metabolic diseases.
  • To emphasize the need for specialized metabolic centers and multi-professional teams.
  • To highlight the importance of networking centers for research and improved patient care.

Summary:

  • Specialized metabolic centers are vital for managing rare metabolic diseases, ensuring continuous improvement in treatment principles.

Related Experiment Videos

  • These centers must provide standardized outcome evaluation, strict quality assurance, and optimal psychosocial support.
  • Networking national and international centers is imperative for accumulating sufficient patient data for robust clinical research.

    • Impact:

    • Improved diagnostic and therapeutic standards for rare metabolic diseases.
    • Enhanced comprehensive care and psychosocial support for affected patients and families.
    • Advancement of clinical research through collaborative efforts and larger sample sizes, leading to better treatment strategies.